CD8A and COVID-19: Given the association of type I IFN–targeting autoantibodies and the association with COVID-19 severity (67, 68), potential preference for IFN-λ rather than type I IFN signaling to promote CD8 T cell immunity may represent a crucial defense mechanism against SARS-CoV-2 infection and COVID-19.